127 related articles for article (PubMed ID: 2214502)
1. Ether lipids in cancer chemotherapy.
Berdel WE; Okamoto S
Keio J Med; 1990 Jun; 39(2):75-8. PubMed ID: 2214502
[TBL] [Abstract][Full Text] [Related]
2. Ether lipids and derivatives as investigational anticancer drugs. A brief review.
Berdel WE
Onkologie; 1990 Aug; 13(4):245-50. PubMed ID: 2234777
[TBL] [Abstract][Full Text] [Related]
3. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrow.
Vogler WR; Berdel WE; Geller RB; Brochstein JA; Beveridge RA; Dalton WS; Miller KB; Lazarus HM
Adv Exp Med Biol; 1996; 416():389-96. PubMed ID: 9131178
[TBL] [Abstract][Full Text] [Related]
5. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
Wagner BA; Buettner GR; Burns CP
Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
[TBL] [Abstract][Full Text] [Related]
6. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
[TBL] [Abstract][Full Text] [Related]
7. Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience.
Berdel WE
Lipids; 1987 Nov; 22(11):970-3. PubMed ID: 3328030
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
9. The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe.
Lohmeyer M; Workman P
Biochem Pharmacol; 1993 Jan; 45(1):77-86. PubMed ID: 8424826
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action.
Diomede L; Colotta F; Piovani B; Re F; Modest EJ; Salmona M
Int J Cancer; 1993 Jan; 53(1):124-30. PubMed ID: 8416196
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs.
Vogler WR
Leuk Lymphoma; 1994 Mar; 13(1-2):53-60. PubMed ID: 8025524
[TBL] [Abstract][Full Text] [Related]
12. Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation.
Vogler WR; Olson AC; Okamoto S; Somberg LB; Glasser L
Lipids; 1987 Nov; 22(11):919-24. PubMed ID: 3328027
[TBL] [Abstract][Full Text] [Related]
13. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
14. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
Yamazaki T; Sieber F
Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
[TBL] [Abstract][Full Text] [Related]
15. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
[TBL] [Abstract][Full Text] [Related]
16. Purging of acute myeloid leukemic cells by ether lipids and hyperthermia.
Okamoto S; Olson AC; Berdel WE; Vogler WR
Blood; 1988 Nov; 72(5):1777-83. PubMed ID: 3052629
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
[No Abstract] [Full Text] [Related]
18. Antineoplastic activity of conjugates of lipids and 1-beta-D-arabinofuranosylcytosine.
Berdel WE; Danhauser S; Schick HD; Hong CI; West CR; Fromm M; Fink U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):943-6. PubMed ID: 3444389
[TBL] [Abstract][Full Text] [Related]
19. Elimination of leukemic cells by the combined use of ether lipids in vitro.
Okamoto S; Olson AC; Vogler WR
Cancer Res; 1987 May; 47(10):2599-603. PubMed ID: 3471316
[TBL] [Abstract][Full Text] [Related]
20. Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3.
Heesbeen EC; Rijksen G; van Heugten HG; Verdonck LF
Leuk Res; 1995 Jun; 19(6):417-25. PubMed ID: 7596155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
